FI945581A0 - Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina - Google Patents
Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineinaInfo
- Publication number
- FI945581A0 FI945581A0 FI945581A FI945581A FI945581A0 FI 945581 A0 FI945581 A0 FI 945581A0 FI 945581 A FI945581 A FI 945581A FI 945581 A FI945581 A FI 945581A FI 945581 A0 FI945581 A0 FI 945581A0
- Authority
- FI
- Finland
- Prior art keywords
- neuroprotective
- hydrogen
- arylalkoxybenzyl
- antiepileptic
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306886A GB9306886D0 (en) | 1993-04-01 | 1993-04-01 | Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation |
| PCT/EP1994/000802 WO1994022808A1 (en) | 1993-04-01 | 1994-03-15 | Substituted (arylalkoxybenzyl)aminopropanamide derivatives, their preparation and use as anti-epileptic, neuroprotective and antidepressant agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI945581A0 true FI945581A0 (fi) | 1994-11-28 |
| FI945581A FI945581A (fi) | 1994-11-28 |
Family
ID=10733215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI945581A FI945581A (fi) | 1993-04-01 | 1994-11-28 | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5446066A (ko) |
| EP (1) | EP0643688B1 (ko) |
| JP (1) | JP3542599B2 (ko) |
| KR (1) | KR950701904A (ko) |
| CN (1) | CN1035938C (ko) |
| AT (1) | ATE168991T1 (ko) |
| AU (1) | AU667164B2 (ko) |
| CA (1) | CA2135783C (ko) |
| DE (1) | DE69412016T2 (ko) |
| ES (1) | ES2122253T3 (ko) |
| FI (1) | FI945581A (ko) |
| GB (1) | GB9306886D0 (ko) |
| HU (1) | HUT68256A (ko) |
| IL (1) | IL108969A (ko) |
| NZ (1) | NZ262907A (ko) |
| PL (1) | PL306537A1 (ko) |
| RU (1) | RU94046141A (ko) |
| WO (1) | WO1994022808A1 (ko) |
| ZA (1) | ZA941963B (ko) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9515412D0 (en) * | 1995-07-27 | 1995-09-27 | Pharmacia Spa | 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
| GB9706730D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | 2-[(3-substituted)-5-Isoxazolymethylaminojalkanamid derivatives |
| CA2310664C (en) | 1997-11-21 | 2008-03-11 | Euro-Celtique S.A. | Substituted 2-aminoacetamides and the use thereof |
| GB9727523D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Alpha-aminoamide derivatives useful as analgesic agents |
| US6281211B1 (en) | 1999-02-04 | 2001-08-28 | Euro-Celtique S.A. | Substituted semicarbazides and the use thereof |
| JP2002541215A (ja) * | 1999-04-09 | 2002-12-03 | ユーロ−セルティック エス． ア． | ナトリウムチャネル遮断薬組成物およびその使用 |
| NZ531586A (en) | 2001-09-03 | 2005-09-30 | Newron Pharm Spa | Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| US6667327B2 (en) | 2002-02-04 | 2003-12-23 | Hoffmann-La Roche Inc. | Pyridine amido derivatives |
| EP1438956A1 (en) * | 2003-01-16 | 2004-07-21 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful as antimigraine agents |
| AR044007A1 (es) | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
| EP1524265A1 (en) * | 2003-10-15 | 2005-04-20 | Newron Pharmaceuticals S.p.A. | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors |
| CA2543287A1 (en) * | 2003-10-23 | 2005-05-06 | F.Hoffmann-La Roche Ag | Benzazepine derivatives as mao-b inhibitors |
| EP1588704A1 (en) | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| PT1809271E (pt) * | 2004-09-10 | 2010-08-30 | Newron Pharm Spa | Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio |
| EP1870097A1 (en) * | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1140748A (en) * | 1966-06-23 | 1969-01-22 | Ici Ltd | New carboxylic acid derivatives |
| US4049663A (en) * | 1972-06-06 | 1977-09-20 | Allen & Hanburys Limited | Ethylene diamine derivatives |
| DE3010599A1 (de) * | 1979-03-22 | 1980-10-09 | Continental Pharma | Derivate von glycinamid, deren herstellung und verwendung |
| FR2480747A1 (fr) * | 1980-04-17 | 1981-10-23 | Roques Bernard | Derives d'acides amines et leur application therapeutique |
| US4728668A (en) * | 1985-04-16 | 1988-03-01 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4631287A (en) * | 1985-04-16 | 1986-12-23 | Usv Pharmaceutical Corp. | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4725619A (en) * | 1985-04-16 | 1988-02-16 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| IL94466A (en) * | 1989-05-25 | 1995-01-24 | Erba Carlo Spa | Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation |
-
1993
- 1993-04-01 GB GB939306886A patent/GB9306886D0/en active Pending
-
1994
- 1994-03-14 IL IL10896994A patent/IL108969A/en not_active IP Right Cessation
- 1994-03-15 EP EP94910419A patent/EP0643688B1/en not_active Expired - Lifetime
- 1994-03-15 ES ES94910419T patent/ES2122253T3/es not_active Expired - Lifetime
- 1994-03-15 AT AT94910419T patent/ATE168991T1/de not_active IP Right Cessation
- 1994-03-15 AU AU62842/94A patent/AU667164B2/en not_active Ceased
- 1994-03-15 JP JP52142994A patent/JP3542599B2/ja not_active Expired - Fee Related
- 1994-03-15 HU HU9403810A patent/HUT68256A/hu unknown
- 1994-03-15 DE DE69412016T patent/DE69412016T2/de not_active Expired - Fee Related
- 1994-03-15 RU RU94046141/04A patent/RU94046141A/ru unknown
- 1994-03-15 CA CA002135783A patent/CA2135783C/en not_active Expired - Fee Related
- 1994-03-15 WO PCT/EP1994/000802 patent/WO1994022808A1/en active IP Right Grant
- 1994-03-15 KR KR1019940704321A patent/KR950701904A/ko not_active Application Discontinuation
- 1994-03-15 NZ NZ262907A patent/NZ262907A/en unknown
- 1994-03-15 PL PL94306537A patent/PL306537A1/xx unknown
- 1994-03-15 CN CN94190168A patent/CN1035938C/zh not_active Expired - Fee Related
- 1994-03-22 US US08/215,628 patent/US5446066A/en not_active Expired - Lifetime
- 1994-04-21 ZA ZA941963A patent/ZA941963B/xx unknown
- 1994-11-28 FI FI945581A patent/FI945581A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6284294A (en) | 1994-10-24 |
| WO1994022808A1 (en) | 1994-10-13 |
| HUT68256A (en) | 1995-06-28 |
| AU667164B2 (en) | 1996-03-07 |
| ES2122253T3 (es) | 1998-12-16 |
| IL108969A (en) | 1998-10-30 |
| CN1104017A (zh) | 1995-06-21 |
| JP3542599B2 (ja) | 2004-07-14 |
| EP0643688A1 (en) | 1995-03-22 |
| IL108969A0 (en) | 1994-06-24 |
| DE69412016T2 (de) | 1999-02-11 |
| US5446066A (en) | 1995-08-29 |
| CA2135783A1 (en) | 1994-10-13 |
| JPH07507814A (ja) | 1995-08-31 |
| KR950701904A (ko) | 1995-05-17 |
| ATE168991T1 (de) | 1998-08-15 |
| CA2135783C (en) | 2005-06-07 |
| ZA941963B (en) | 1994-10-19 |
| NZ262907A (en) | 1996-02-27 |
| RU94046141A (ru) | 1996-09-27 |
| FI945581A (fi) | 1994-11-28 |
| EP0643688B1 (en) | 1998-07-29 |
| GB9306886D0 (en) | 1993-05-26 |
| PL306537A1 (en) | 1995-04-03 |
| CN1035938C (zh) | 1997-09-24 |
| DE69412016D1 (de) | 1998-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945581A0 (fi) | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina | |
| DK0628311T3 (da) | Xanthinderivater som antidepressive midler | |
| DE69325454D1 (de) | Taxol-derivate | |
| MY116280A (en) | A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist | |
| DE69313051D1 (de) | Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung | |
| DE69231445D1 (de) | Triazole enthaltende antifungizide mittel | |
| DK0616609T3 (da) | Nitroanilinderivater og deres anvendelse som antitumormidler | |
| FI945582A (fi) | Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
| FI961793A (fi) | Muistia parantavina aineina käyttökelpoiset 3-aryyli-4-alkyyli- ja 4,5-dialkyyli 4H-1,2,4-triatsolit | |
| DK0667860T3 (da) | Azaspiroalkan-derivater som terapeutiske midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: PHARMACIA & UPJOHN S.P.A. |